No Detail Found!

Regulation of alternative splicing and the case of Bcl-x.

Author(s)
Lulzim Shkreta Department of Microbiology and Infectious Diseases, Faculty of Medicine and Health Sciences, Universite de Sherbrooke, Sherbrooke, Quebec, Canada
Alexandre Cloutier Department of Microbiology and Infectious Diseases, Faculty of Medicine and Health Sciences, Universite de Sherbrooke, Sherbrooke, Quebec, Canada
Johanne Toutant Department of Microbiology and Infectious Diseases, Faculty of Medicine and Health Sciences, Universite de Sherbrooke, Sherbrooke, Quebec, Canada
Herve Vennin Rendos Department of Microbiology and Infectious Diseases, Faculty of Medicine and Health Sciences, Universite de Sherbrooke, Sherbrooke, Quebec, Canada
Benoit Chabot Department of Microbiology and Infectious Diseases, Faculty of Medicine and Health Sciences, Universite de Sherbrooke, Sherbrooke, Quebec, Canada
Abstract
Almost every human pre-messenger RNA is alternatively spliced to produce mRNA variants that often encode proteins with distinct functions. How regulation of alternative splicing is achieved is still poorly understood. The goals of this article is to review our current knowledge of how regulatory factors orchestrate splice site selection, particularly in the context of cancer. As our own investigations into this process in the last 10 years have focused on the apoptotic gene Bcl-x, we will indicate how this experimental model system has helped us gain insight into the complexity of molecular strategies and the role of unexpected regulators in the control of splice site selection. Notably, our recent work has also revealed how the DNA damage pathway and upstream signalling routes are converging to regulate alternative splicing decisions.
Publication Details
Page(s) 27-38
DOI DOI not available
Published Journal: Pakistan Journal of Biochemistry and Molecular Biology , Volume: 48, Issue: 2, Year: 2015

Request the full text from PASTIC

0

Citations

0

Downloads

31

Views